<DOC>
	<DOCNO>NCT00883493</DOCNO>
	<brief_summary>The purpose study compare efficacy quetiapine fumarate monotherapy quetiapine fumarate combination lithium treatment major depressive episode patient bipolar disorder .</brief_summary>
	<brief_title>Efficacy Safety Quetiapine Versus Quetiapine Plus Lithium Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Outpatients meet diagnostic criterion bipolar disorder I bipolar disorder II recent episode depress The total score scale 's used evaluation depression ( HAMD ) ≥20 The total score scale ' used evaluation mania ( YMRS ) ≤12 Patients current DSMIVTR Axis I disorder bipolar disorder within 6 month enrollment . Patients pose current serious suicidal homicidal risk Use drug induce inhibit hepatic metabolizing enzyme within 14 day randomisation Patients unable discontinue psychoactive medication , include antidepressant , antipsychotic , mood stabilizer least 7 day prior randomisation consistent pharmacokinetics drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Acute bipolar depression</keyword>
	<keyword>Lithium carbonate</keyword>
	<keyword>quetiapine fumarate</keyword>
	<keyword>MADRS</keyword>
</DOC>